Effects of the COVID-19 pandemic on clinically diagnosed psychiatric disorders in persons with type 2 diabetes.
COVID-19
SARS-CoV-2
antidepressants
anxiety
depression
diabetes
stress
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
20
10
2021
accepted:
13
04
2022
pubmed:
16
4
2022
medline:
22
7
2022
entrez:
15
4
2022
Statut:
ppublish
Résumé
To examine whether the incidence rates of diagnosed depression, anxiety disorders and stress reactions, as well as prescription rates of antidepressants and anxiolytics were higher during the COVID-19 pandemic than before in persons with type 2 diabetes in Germany. Contrary to earlier studies, clinical diagnoses of psychiatric disorders (ICD classification) were used. The German Disease Analyzer (DA) database is an outpatient database containing routine data on patients´ diseases and treatments provided by a representative panel of physician practices selected from across Germany. We assessed incidence rates of depressive disorders (ICD-10: F32, F33), anxiety disorders (F41) and stress reactions (F43) in quarters from January 2019 to March 2021 in 95,765 people with type 2 diabetes included in the DA in 2019 (mean age 68.9 years, 58% men). Prescription rates of antidepressants and anxiolytics in quarters from January 2020 to March 2021 were compared with prescription rates from 1 year earlier. During the study period, the incidence rate of newly diagnosed depressive disorders in persons with type 2 diabetes declined slightly, while the incidence rates of anxiety and stress disorders remained largely constant. The rates of new prescriptions for antidepressants and anxiolytics were lower in all quarters of 2020 and in the first quarter of 2021 than in the quarters 1 year earlier. Diabetes-related complications were more prevalent in persons with incident psychiatric disorders than in those without. No increase in the incidence rates of clinically diagnosed psychiatric disorders was observed during the COVID-19 pandemic in Germany in persons with type 2 diabetes.
Identifiants
pubmed: 35426166
doi: 10.1111/dme.14852
pmc: PMC9111356
doi:
Substances chimiques
Anti-Anxiety Agents
0
Antidepressive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14852Informations de copyright
© 2022 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Références
JAMA Netw Open. 2020 Sep 1;3(9):e2019686
pubmed: 32876685
Int J Soc Psychiatry. 2021 Nov;67(7):892-906
pubmed: 33794717
Diabetes Res Clin Pract. 2021 Mar;173:108343
pubmed: 32711002
Diabetes Care. 2022 Jan 1;45(1):74-82
pubmed: 34753805
J Diabetes Complications. 2021 Apr;35(4):107858
pubmed: 33573890
BMC Public Health. 2021 Nov 11;21(1):2068
pubmed: 34763688
Diabet Med. 2021 Sep;38(9):e14611
pubmed: 34053106
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):93-98
pubmed: 33316765
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):535-545
pubmed: 32408118
Healthcare (Basel). 2021 Apr 18;9(4):
pubmed: 33919519
J Diabetes. 2021 Apr;13(4):339-352
pubmed: 33351239
Diabetes Res Clin Pract. 2020 Sep;167:108350
pubmed: 32710996
J Prim Care Community Health. 2021 Jan-Dec;12:2150132721996898
pubmed: 33719697
Diabet Med. 2021 May;38(5):e14498
pubmed: 33314244
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Int J Clin Pharmacol Ther. 2018 Oct;56(10):459-466
pubmed: 30168417
Research (Wash D C). 2020 Apr 19;2020:2402961
pubmed: 32377638
Diabetol Metab Syndr. 2020 Aug 31;12:76
pubmed: 32879637
Int J Environ Res Public Health. 2022 Feb 15;19(4):
pubmed: 35206374
BMJ Open Diabetes Res Care. 2021 Jan;9(1):
pubmed: 33431602
Diabet Med. 2022 Aug;39(8):e14852
pubmed: 35426166
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1603-1605
pubmed: 32862099
Int J Clin Pharmacol Ther. 2009 Oct;47(10):617-26
pubmed: 19825325
Geriatr Nurs. 2022 Jan-Feb;43:58-63
pubmed: 34823078
Diabetes Care. 2022 Jan 1;45(1):42-58
pubmed: 34740911
Dtsch Arztebl Int. 2020 Dec 11;117(50):861-867
pubmed: 33295275
Diabet Med. 2020 Jul;37(7):1146-1154
pubmed: 32392380
J Diabetes Complications. 2020 Dec;34(12):107748
pubmed: 33059981
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833
pubmed: 32798471